Impax Asset Management Group plc Increases Holdings in Enfusion, Inc. (NYSE:ENFN)

Impax Asset Management Group plc raised its stake in Enfusion, Inc. (NYSE:ENFN) by 25.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 676,948 shares of the company’s stock after acquiring an additional 136,948 shares during the period. Impax Asset Management Group plc owned approximately 0.53% of Enfusion worth $6,424,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Allspring Global Investments Holdings LLC purchased a new stake in Enfusion during the 1st quarter valued at about $44,000. RiverPark Advisors LLC purchased a new stake in shares of Enfusion during the second quarter valued at approximately $68,000. Arizona State Retirement System bought a new stake in shares of Enfusion during the second quarter valued at approximately $86,000. Price T Rowe Associates Inc. MD purchased a new position in Enfusion in the 1st quarter worth approximately $102,000. Finally, Quadrature Capital Ltd bought a new position in Enfusion in the 1st quarter valued at approximately $109,000. 81.05% of the stock is currently owned by institutional investors.

Enfusion Trading Up 2.6 %

Enfusion stock opened at $8.95 on Wednesday. Enfusion, Inc. has a 12 month low of $7.52 and a 12 month high of $10.45. The stock has a fifty day simple moving average of $8.77 and a two-hundred day simple moving average of $8.84. The firm has a market cap of $1.15 billion, a price-to-earnings ratio of 223.81, a PEG ratio of 2.51 and a beta of 0.93.

Enfusion (NYSE:ENFN) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). The business had revenue of $49.46 million during the quarter, compared to the consensus estimate of $50.27 million. Enfusion had a return on equity of 6.17% and a net margin of 1.98%. On average, equities research analysts forecast that Enfusion, Inc. will post 0.07 EPS for the current fiscal year.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.